WallStreetZenWallStreetZen

NASDAQ: ZVSA
Zyversa Therapeutics Inc Stock Ownership - Who owns Zyversa Therapeutics?

Insider buying vs selling

Have Zyversa Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ZVSA insiders and whales buy or sell their stock.

ZVSA Shareholders

What type of owners hold Zyversa Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Incon Co Ltd197.13%1,497,199$8.38MInsider
Daniel J. Oconnor181.39%1,377,598$7.71MInsider
Stephen C. Glover64.88%492,756$2.76MInsider
Agp Alliance Global Partners Corp58.83%446,843$2.50MInsider
Larkspur Health LLC31.11%236,273$1.32MInsider
Anson Funds Management LP21.16%160,671$899.76kInstitution
Peter Wolfe5.87%44,585$249.68kInsider
Pablo A. Guzman3.43%26,021$145.72kInsider
Two Sigma Securities LLC2.46%18,671$104.56kInstitution
Nicholas A. Labella Jr.2.38%18,094$101.33kInsider

1 of 2

ZVSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZVSA4.63%95.37%
XCUR0.89%99.11%Net SellingNet Selling
ALZN0.97%99.03%Net BuyingNet Buying
ENSC0.72%57.99%
TCBP0.12%11.35%

Zyversa Therapeutics Stock Ownership FAQ

Who owns Zyversa Therapeutics?

Zyversa Therapeutics (NASDAQ: ZVSA) is owned by 26.54% institutional shareholders, 546.44% Zyversa Therapeutics insiders, and 0.00% retail investors. Incon Co Ltd is the largest individual Zyversa Therapeutics shareholder, owning 1.50M shares representing 197.13% of the company. Incon Co Ltd's Zyversa Therapeutics shares are currently valued at $7.91M.

If you're new to stock investing, here's how to buy Zyversa Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.